The EPS projection of Varian Medical Systems, Inc. (NYSE:VAR) for quarter ended 2016-09-30 is $1.31. Last week, the projection for EPS was $1.31 against target of $1.31, a month earlier. While 2-months ago, this projection was $1.31 versus forecast of $1.31a quarter months earlier, posting a deviation of 0%.
Varian Medical Systems, Inc. (NYSE:VAR) posted that 18 days earlier, the share price was revised 3 times on upside. In addition, negative revisions were 1.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 1, and 1, correspondingly.
The per-share earnings downgrade for Varian Medical Systems, Inc. (NYSE:VAR) in the preceding 30 and 120 were 0 and 2. While in 60 and 90 days were 0, and 2, in that order.
Varian Medical Systems, Inc. (NYSE:VAR) EPS target was $1.31 for the quarter closed 2. It was based on 4 calls. As on 2016-04-27 the EPS was $1.09. The change was $0.01, posting a deviation of 0.93%. The price projections gave a standard deviation of 0.01.
Quarterly Sales Estimates
Varian Medical Systems, Inc. (NYSE:VAR) sales prediction for the fiscal 2017 stands at $917.3 and the median estimate is at $917.3. Almost 2 analysts gave sales target.
Among this, the highest sales estimate is $917.4 while the lowest target is $917.2 showing standard deviation of 0.141%.
As many as 2 analysts have positive sales targets revision while 2 reduced sales estimates, posting a deviation of 0%.
Last month, 2 experts have positive sales number revision. Also, 2 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast, posting a deviation of -0.374%.
1 Chart Pattern Every Investor Should Know